Impact of a cost-effective, nutritionally optimized supplement on body-composition and functional measures: A multicentric randomized-control trial among older adults at risk of malnutrition/or-malnourished (I-CARE Study)
Project Description
Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation. Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.
Project Duration
2025 - 2025
Project Lead
Dr. Sucharita S
Authors
Dr Sucharit S, Dr Arvind K
Project Status
completed
Project Type
Government funding (Funded by ICMR)